Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : The Critical Investing Workshop -- Ignore unavailable to you. Want to Upgrade?

To: T L Comiskey who wrote (9465)	3/28/2000 10:28:00 AM
From: Dealer	Read Replies (1) \| Respond to of 35685

RNWK--DigiScents, Inc., and Clontech Laboratories, Inc. Discover Novel Human Olfactory Genes BUSINESS WIRE - March 28, 2000 09:47 OAKLAND, Calif., Mar 28, 2000 (BUSINESS WIRE) -- DigiScents, Inc. (www.digiscents.com), the pioneer of digital scent technology, and CLONTECH, a leading biotechnology research firm, have announced a major advance in understanding the human sense of smell. The companies have isolated, cloned and sequenced 126 human olfactory receptor genes. This latest discovery combined with publicly available olfactory research gives DigiScents access to close to half of the estimated 1000 genes that code for human olfactory receptors. Olfactory receptors are expressed in neurons of the olfactory epithelium and allow humans to detect and distinguish between smells ranging from flowers to pizza and chocolate to burning wood. "This milestone represents a significant development in aromagenomics," states DigiScents' CEO, Joel Bellenson, referring to the application of molecular biology to the field of olfaction. "DigiScents is combining biotechnology, informatics, and sensory research to create a digital index that will revolutionize the world of smell." Kenneth Fong, president and founder of CLONTECH, and the most recent new member of the DigiScents advisory board, stated: "We view this research partnership with DigiScents as an exciting venture into a surprisingly unmapped territory for biotech." About DigiScents, Inc. DigiScents is partnering with leading web sites and interactive media companies to scent enable the Internet. With DigiScents(tm) Digital Scent Technology, consumers will be able to enjoy more lifelike and memorable experiences with scented Web sites, e-mail, movies, music, e-commerce, interactive games, and online advertising. In October 1999, DigiScents (www.digiscents.com) first announced its complete solution for digitizing and broadcasting scents over the Internet. Through its partnership with RealNetworks (Nasdaq: RNWK), DigiScents ScentStream(tm) software will be auto-downloaded to almost 100 million RealPlayer users. Through its partnership with Hong Kong-listed Pacific Century CyberWorks (PCCW; HKSE:1186), DigiScents technology will be available across all of the Asia-Pacific via NOW, PCCW's enormous Internet, e-commerce, and interactive television network. DigiScents is a privately held corporation located in Oakland, California. The company was founded in February 1999 by Dexster Smith and Joel Bellenson. Bellenson and Smith also founded DoubleTwist (www.doubletwist.com), formerly Pangea Systems Inc., a world leading biotechnology company. About CLONTECH Laboratories, Inc. CLONTECH, recently acquired by Becton-Dickinson, is a biotechnology company currently employing 360 people, including 60 Ph.D. scientists. The company produces and markets products to academic and pharmaceutical labs in the United States and 30 other countries. The Palo Alto-based lab received R&D 100 Awards for five innovative products in 1996, 1997, and 1998. DigiScents(tm), ScentStream(tm), and iSmell(tm) are trademarks of DigiScents, Inc. RealNetworks(R) and RealPlayer(R) are trademarks or registered trademarks of RealNetworks, Inc. All other companies or products listed herein are trademarks or registered trademarks of their respective owners.